Atraverse Medical, Inc.

Cardiff by the Sea, CA · Founded 2022 · Medtech · Acquired

Flexible transeptal catheter access system for cardiac procedures

Claim this profile

Follows are private to you and power your alerts

Updated · atraversemedical.com

Sector
Medtech
Headquarters
Cardiff by the Sea, CA
Founded
2022
Latest Form D
$8.6M, May 2025
Total capital
$31.4M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$31.4M
5 Form D · last May 2025
18 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
9 pending · first 2025
Rank in peer group#498 of 1112

Capital timeline

202320242025FEDERAL ↑EQUITY ↓Cumulative $31.4M1st Form D$3.2M2nd Form D$400K3rd Form D$4.1M4th Form D$15M5th Form D$8.6M
202320242025FEDERAL ↑EQUITY ↓Cumulative $31.4M3rd Form D$4.1M5th Form D$8.6M

Latest events

  • Private capital raisedForm D · SEC · 5th filing$8.6M
  • Private capital raisedForm D · SEC · 4th filing$15M
  • Private capital raisedForm D · SEC · 3rd filing$4.1M
  • Private capital raisedForm D · SEC · 2nd filing$400K
  • Private capital raisedForm D · SEC · 1st filing$3.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#498 · top 45%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Eric R SauterDirectorNamed in SEC Form D filings
  • John R SlumpExecutive Officer, DirectorNamed in SEC Form D filings
  • Steven R MickelsenDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 10
Show all 10 patent records
  • Methods, Systems, And Apparatuses For Perforating Tissue StructuresSep 25, 2025 · Application 19229784Pending
  • Methods, Systems, And Apparatuses For Perforating Tissue StructuresJul 1, 2025 · US 12,343,074Granted
  • Methods, Systems, And Apparatuses For Perforating Tissue StructuresApplication 63667375Pending
  • Systems, Devices, And Methods For Delivering Radiofrequency Current For Tissue PerforationApplication 63667367Pending
  • System, Devices, And Methods For Delivering Radiofrequency Current For Tissue PerforationApplication 63625845Pending
  • Methods, Systems, And Apparatuses For Perforating Tissue StructuresApplication PCTUS2023086043Pending
  • Methods, Systems, And Apparatuses For Perforating Tissue StructuresApplication 63586940Pending
  • Methods, Systems, And Apparatuses For Perforating Tissue StructuresApplication PCTUS2025036515Pending
  • Methods, Systems, And Apparatuses For Perforating Tissue StructuresApplication 63435659Pending
  • System, Devices, And Methods For Delivering Radiofrequency Current For Tissue PerforationApplication PCTUS2025013215Pending
  • ElectraDx, Inc.Similar federal contract value in Medtech · null in contracts
  • Qnovia, Inc.Similar federal contract value in Medtech · null in contracts
  • Medivis, Inc.Similar federal contract value in Medtech · null in contracts
  • Contamination Source Identification Inc.Similar federal contract value in Medtech · null in contracts
  • RMR Ortho, LLCSimilar federal contract value in Medtech · null in contracts
  • EndoCellutions, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .